Back to Search
Start Over
Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.
- Source :
-
Drug and alcohol dependence [Drug Alcohol Depend] 2020 Mar 01; Vol. 208, pp. 107837. Date of Electronic Publication: 2020 Jan 09. - Publication Year :
- 2020
-
Abstract
- Background: Illicit, medically unsupervised use of buprenorphine (i.e., "diverted use") among vulnerable and underserved populations, such as corrections-involved adults, remains underexplored.<br />Methods: Survey data (2016-2017) collected as part of a clinical assessment of incarcerated adults entering corrections-based substance use treatment in Kentucky were analyzed. For years examined, 12,915 completed the survey. Removing cases for participants who did not reside in Kentucky for >6 months during the one-year pre-incarceration period (n = 908) resulted in a final sample size of 12,007.<br />Results: Over a quarter of the sample reported past-year diverted buprenorphine use prior to incarceration and 21.8 % reported use during the 30-days prior to incarceration, using 6.5 months and 14.3 days on average, respectively. A greater proportion of participants who reported diverted buprenorphine use had previously been engaged with some substance use treatment (77.0 %) and reported greater perceived need for treatment (79.4 %) compared to those who did not report use. Use was more likely among participants who were younger, white, male, and who reported rural or Appalachian residence. Diverted buprenorphine users also evidenced extensive polydrug use and presented with greater substance use disorder severity. Non-medical prescription opioid, heroin, and diverted methadone use were associated with increased odds of diverted buprenorphine use while kratom was not. Diverted methadone use was associated with a 252.9 % increased likelihood of diverted buprenorphine use.<br />Conclusions: Diverted buprenorphine use among participants in this sample was associated with concerning high-risk behaviors and may indicate barriers to accessing opioid agonist therapies for corrections-involved Kentucky residents, particularly those in rural Appalachia.<br />Competing Interests: Declaration of Competing Interest Nothing declared.<br /> (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Subjects :
- Adult
Analgesics, Opioid adverse effects
Analgesics, Opioid therapeutic use
Appalachian Region epidemiology
Buprenorphine adverse effects
Cross-Sectional Studies
Female
Humans
Kentucky epidemiology
Male
Middle Aged
Opiate Substitution Treatment psychology
Opioid-Related Disorders epidemiology
Opioid-Related Disorders psychology
Prescription Drug Diversion psychology
Self Medication psychology
Self Medication trends
Surveys and Questionnaires
Young Adult
Buprenorphine therapeutic use
Correctional Facilities trends
Opiate Substitution Treatment trends
Opioid-Related Disorders drug therapy
Prescription Drug Diversion trends
Substance Abuse Treatment Centers trends
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0046
- Volume :
- 208
- Database :
- MEDLINE
- Journal :
- Drug and alcohol dependence
- Publication Type :
- Academic Journal
- Accession number :
- 31951906
- Full Text :
- https://doi.org/10.1016/j.drugalcdep.2020.107837